These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7895880)

  • 1. Influence of topical monomethyl trisilanol on cataract epidemiology.
    Verin P; Mortemousque B; Coulon P; Williamson W
    Dev Ophthalmol; 1994; 26():40-6. PubMed ID: 7895880
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of the effectiveness of Quinax in the prevention of the development of senile cataract].
    Stankiewicz A; Poppe E; Stasiewicz B; Gołebiowska-Hrycukowa A
    Klin Oczna; 1990 Aug; 92(3-4):52-4. PubMed ID: 2263035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs designed to maintain the transparence of the ocular lens.
    Chanalet L; Lapalus P
    Fundam Clin Pharmacol; 1994; 8(4):322-41. PubMed ID: 7851838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of salicylate in pigmented rabbit ocular tissues after application of a prodrug, sodium monomethyl trisilanol orthohydroxybenzoate: in vivo and ex vivo studies.
    Chanalet L; Ettaiche M; Baudouin C; Lapalus P
    J Ocul Pharmacol Ther; 1995; 11(1):83-94. PubMed ID: 8535961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical aspirin provides protection against galactosemic cataract.
    Gupta SK; Joshi S; Tandon R; Mathur P
    Indian J Ophthalmol; 1997 Dec; 45(4):221-5. PubMed ID: 9567017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of lipid peroxidation and electron microscopic survey of maturation stages during human cataractogenesis: pharmacokinetic assay of Can-C N-acetylcarnosine prodrug lubricant eye drops for cataract prevention.
    Babizhayev MA
    Drugs R D; 2005; 6(6):345-69. PubMed ID: 16274259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of catalin eyed drops in age-related cataract agents].
    Polunin GS; Makarova IA; Bubnova IA
    Vestn Oftalmol; 2010; 126(1):36-9. PubMed ID: 20645574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorometholone-induced cataract after photorefractive keratectomy.
    Bilgihan K; Gürelik G; Akata F; Hasanreisoglu B
    Ophthalmologica; 1997; 211(6):394-6. PubMed ID: 9380362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of the inhibitory effect of Quinax on the progression of senile cataract].
    Prost M; Toczołowski J
    Klin Oczna; 1982 Mar; 84(3):71-2. PubMed ID: 6757553
    [No Abstract]   [Full Text] [Related]  

  • 10. Topical aldose reductase inhibitor formulations for effective lens drug delivery in a rat model for sugar cataracts.
    Kador PF; Randazzo J; Babb T; Koushik K; Takamura Y; Zhu W; Blessing K; Kompella UB
    J Ocul Pharmacol Ther; 2007 Apr; 23(2):116-23. PubMed ID: 17444799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria induce oxidative stress, generation of reactive oxygen species and redox state unbalance of the eye lens leading to human cataract formation: disruption of redox lens organization by phospholipid hydroperoxides as a common basis for cataract disease.
    Babizhayev MA
    Cell Biochem Funct; 2011 Apr; 29(3):183-206. PubMed ID: 21381059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A model of diffusion of anti-cataract drugs into the lens tissue].
    Chasovnikova LV; Formaziuk VE; Sergienko VI; Vlasimirov IuA
    Biofizika; 1990; 35(3):464-8. PubMed ID: 2207189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of postoperative posterior capsular opacification following treatment with diclofenac 0.1% and ketorolac 0.5% ophthalmic solutions: 3-year randomized, double-masked, prospective clinical investigation.
    Flach AJ; Dolan BJ
    Trans Am Ophthalmol Soc; 2000; 98():101-5; discussion 105-7. PubMed ID: 11190013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related cataract and drug therapy: opportunities and challenges for topical antioxidant delivery to the lens.
    Abdelkader H; Alany RG; Pierscionek B
    J Pharm Pharmacol; 2015 Apr; 67(4):537-50. PubMed ID: 25643848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin and cataract.
    Harding JJ
    Ophthalmology; 1999 Dec; 106(12):2233-4. PubMed ID: 10599648
    [No Abstract]   [Full Text] [Related]  

  • 16. Baseline ophthalmic findings in the vitamin E, cataract and age-related maculopathy (VECAT) study.
    Robman LD; Tikellis G; Garrett SK; Harper CA; McNeil JJ; Taylor HR; McCarty CA
    Aust N Z J Ophthalmol; 1999 Dec; 27(6):410-6. PubMed ID: 10641899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of steroid-induced cataract in rat eyes by administration of vitamin-E ophthalmic solution.
    Kojima M; Shui YB; Murano H; Sasaki K
    Ophthalmic Res; 1996; 28 Suppl 2():64-71. PubMed ID: 8883091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro non invasive studies on the ocular lens.
    Lerman S
    Lens Eye Toxic Res; 1989; 6(4):503-14. PubMed ID: 2487267
    [No Abstract]   [Full Text] [Related]  

  • 19. Cataract development after trabeculectomy with mitomycin C: a 1-year study, by L. 'Daugeliene, T. Yamamoto, and Y. Kitazawa. Jpn J Ophthalmol 44:52-7, 2000.
    Patel N
    Surv Ophthalmol; 2000; 45(2):165. PubMed ID: 11033043
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of magnesium taurate on the onset and progression of galactose-induced experimental cataract: in vivo and in vitro evaluation.
    Agarwal R; Iezhitsa I; Awaludin NA; Ahmad Fisol NF; Bakar NS; Agarwal P; Abdul Rahman TH; Spasov A; Ozerov A; Mohamed Ahmed Salama MS; Mohd Ismail N
    Exp Eye Res; 2013 May; 110():35-43. PubMed ID: 23428743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.